USPH
U S PHYSICAL THERAPY INC /NV
+0.34 (+0.41%)83.73USD69.0K成交股數1.2B市值492.5本益比(近四季)1.5股價營收比+8.5%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 214M+8% | 198M+8% | 203M+21% | 197M+18% | 197M+27% | 184M+19% | 168M+12% | 167M+10% | 156M | 155M | 150M | 151M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | 41.9M+1% | 32.8M+5% | 40.1M+38% | 36.9M+9% | 41.6M+47% | 31.1M+2% | 29.1M+4% | 33.9M+5% | 28.4M | 30.5M | 27.9M | 32.2M |
| 毛利率 | 19.6% | 16.5% | 19.8% | 18.7% | 21.1% | 16.9% | 17.3% | 20.3% | 18.2% | 19.7% | 18.6% | 21.3% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 19.0M | 18.3M | 18.1M | 17.4M | 17.5M | 16.2M | 14.4M | 14.2M | 14.1M | 13.9M | 12.0M | 12.1M |
| 營業利益 | 21.9M-12% | 12.5M-36% | 16.8M+31% | 25.3M+63% | 24.9M+67% | 19.6M-908% | 12.8M-19% | 15.6M-22% | 14.9M | −2.4M | 15.9M | 20.1M |
| 營業利益率 | 10.3% | 6.3% | 8.3% | 12.8% | 12.6% | 10.7% | 7.6% | 9.3% | 9.6% | -1.6% | 10.6% | 13.2% |
| 稅後淨利 | 9.9M-20% | 5.0M-49% | 4.2M-37% | 13.1M+75% | 12.4M+54% | 9.9M+1409% | 6.6M-28% | 7.5M-31% | 8.0M | 656K | 9.3M | 10.9M |
| 淨利率 | 4.6% | 2.5% | 2.0% | 6.7% | 6.3% | 5.4% | 3.9% | 4.5% | 5.2% | 0.4% | 6.2% | 7.2% |
| 稀釋 EPS | 0.25-57% | -0.12-115% | -0.44-213% | 0.48+2% | 0.58+26% | 0.80-278% | 0.39-24% | 0.47-27% | 0.46 | -0.45 | 0.51 | 0.64 |
| 稀釋股數 | 15.1M | 15.2M | 15.2M | 15.2M | 15.2M | 15.1M | 15.1M | 15.1M | 15.0M | 14.2M | 15.0M | 13.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 24.9M | 28.4M | 35.6M | 31.1M | 34.1M | 39.2M | 117M | 113M | 132M | 153M | 148M | 161M |
| 應收帳款 | 69.6M | 69.1M | 64.2M | 67.6M | 66.0M | 64.8M | 57.0M | 54.7M | 55.4M | 51.8M | 53.0M | 54.3M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B | 1.0B | 1.0B | 1.0B | 997M | 997M | 1,000M |
| 有息負債 | 215M | 194M | 153M | 151M | 152M | 157M | 133M | 136M | 137M | 139M | 141M | 143M |
| 總負債 | 482M | 459M | 434M | 414M | 414M | 421M | 358M | 353M | 345M | 345M | 342M | 344M |
| 股東權益 | 449M | 469M | 476M | 504M | 501M | 497M | 483M | 485M | 480M | 476M | 492M | 488M |
| 負債比 | 38.6% | 37.0% | 36.0% | 34.6% | 35.1% | 35.7% | 34.8% | 34.5% | 33.9% | 34.6% | 34.3% | 34.4% |
| 淨現金(現金 − 有息負債) | −191M | −166M | −117M | −120M | −118M | −118M | −16.0M | −22.8M | −4.5M | 13.8M | 6.2M | 17.3M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 3.8M-181% | – | – | – | −4.7M | – | – | 4.4M | – | – | – |
| 資本支出 | – | 5.4M | – | – | – | 2.6M | – | – | 1.8M | – | – | – |
| 自由現金流 | – | −1.6M-78% | – | – | – | −7.3M | – | – | 2.6M | – | – | – |
| 折舊攤銷 | 5.6M | 6.0M | 5.3M | 5.5M | 5.7M | 5.9M | 4.2M | 4.3M | 4.1M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -0.8% | – | – | – | -3.9% | – | – | 1.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 791M
| Net Patient Revenues | 650M | 82.3% | +16.0% |
|---|---|---|---|
| Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues | 131M | 16.5% | +17.8% |
| Management Contract Revenues | 9.6M | 1.2% | -2.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 781M | +16.3% | 39.6M | 5.1% | 1.42 | 61.0M |
| FY2024 | 671M | +11.0% | 31.4M | 4.7% | 1.84 | 65.8M |
| FY2023 | 605M | +9.3% | 28.2M | 4.7% | 1.28 | 72.7M |
| FY2022 | 553M | +11.7% | 32.2M | 5.8% | 2.25 | 50.3M |
| FY2021 | 495M | +17.0% | 40.8M | 8.2% | 2.41 | 68.2M |
| FY2020 | 423M | -12.2% | 35.2M | 8.3% | 2.48 | 92.4M |
| FY2019 | 482M | +6.2% | 40.0M | 8.3% | 2.45 | 52.3M |
| FY2018 | 454M | – | 34.9M | 7.7% | 1.31 | 65.8M |